Kane Biotech Q1 Loss Widens Despite Revenue Gains; to Report a Q2 Gain Following Sale of STEM Animal Health

Kane Biotech (KNE.V) Thursday said its first-quarter loss widened even as revenue rose by 39%.. The company, which makes products to prevent and remove microbial biofilms, said it lost $1.4 million, o

MT NewswiresMay 23 16:51 ET

Kane Biotech to Release First Quarter 2024 Financial Results on May 23, 2024

WINNIPEG, Manitoba, May 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the "Company" or "Kane Biotech"), a biotechnology company engaged in the research, development and c

GlobeNewswireMay 16 08:00 ET

Kane Biotech Expands Its Wound Care Portfolio With Patented Schultz Biofilm Wound Map

Named in Honour of the late Dr. Greg Schultz, Former Professor Emeritus at the University of Florida and Chief Science Officer of Kane BiotechWINNIPEG, Manitoba, May 15, 2024 (GLOBE NEWSWIRE) -- Kan

GlobeNewswireMay 15 08:00 ET

Kane Biotech to Host Investor Webinar

What the sale of STEM Animal Health means for Kane going forward – Thursday April 18th, 2024 at 4:15pm Eastern TimeWINNIPEG, Manitoba, April 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KN

GlobeNewswireApr 16 09:15 ET

Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products

An important step in Kane becoming a market leader in the growing high-value wound care and dermatological marketsWINNIPEG, Manitoba, April 15, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE

GlobeNewswireApr 15 09:15 ET

Kane Biotech Brief: Says Otal Revenue for the Three Months Ended December 31, 2023 Was $764,997

04:06 PM EDT, 03/26/2024 (MT Newswires) -- Kane Biotech Brief: Says otal revenue for the three months ended December 31, 2023 was $764,997

MT NewswiresMar 26 16:06 ET